@misc{10481/91518,
year = {2020},
month = {10},
url = {https://hdl.handle.net/10481/91518},
abstract = {The activity of azithromycin against enteritis-producing agents other than Campylobacter spp. was studied. The susceptibility to azithromycin, through gradient test, of 88 clinical isolates (51 Salmonella spp., 23 Aeromonas spp., 10 Shigella sonnei and 4 Yersinia enterocolitica) for one year was studied prospectively. The results were compared with the activity of ampicillin, trimethoprim-sulfamethoxazole and ciprofloxacin by microdilution. For azithromycin, the minimum inhibitory concentration (MIC) 50 and MIC90 were 4 and 12 mg/l, respectively. Six (6.8%) isolates were simultaneously resistant to ampicillin, trimethoprim- sulfamethoxazole and ciprofloxacin, and 3 (50%) of them presented a MIC >256 mg/l. Azithromycin may be a good empirical therapeutic option for the treatment of bacterial enteritis.},
publisher = {New Microbiol},
title = {Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter},
author = {Casanovas-Moreno-Torres, Isabel and Gutiérrez-Soto, Blanca and Diana Modovan, Teodora and Expósito Ruiz, Manuela and Navarro-Marí, José María and Gutiérrez Fernández, José},
}